BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical & Diagnostic

Brii Biosciences Secures Intellectual Property Rights for HBV Treatment from VBI Vaccines

Brii Biosciences Limited ("Brii Bio"), a leader in developing innovative treatments for diseases with significant unmet needs, has announced a strategic ac...

February 14, 2024 | News

William Lin Discusses QIAGEN's Role in Transforming Healthcare in Asia-Pacific with Innovative Molecular Diagnostics

In a significant stride towards enhancing healthcare diagnostics in the Asia-Pacific region, QIAGEN has recently garnered attention with the approval of it...

February 13, 2024 | Interaction

Gilead Sciences Bolsters Liver Portfolio Through Acquisition of CymaBay Therapeutics

Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. announced today a definitive agreement whereby Gilead will acquire CymaBay for $32.50 ...

February 13, 2024 | News

Aptar Partners with Biogen for Digital Health Solutions

New partnership model leverages Aptar Digital Health’s capabilities to support the development and operation of new and existing digital health sol...

February 12, 2024 | News

BioAro and MyCare Revolutionize Genetic Testing, Advancing Detection of Serious Diseases

BioAro Inc., a leading international biotechnology company, has partnered with Assured Diagnostics Inc. to make their cutting-edge Whole Genome Sequencing ...

February 12, 2024 | News

Telix to Acquire QSAM Biosciences, Bolstering Bone Cancer Targeting

153Sm-DOTMP utilizes a cutting-edge chelating agent to deliver Samarium-153 radioisotope, offering potential advancements in bone cancer treatment....

February 08, 2024 | News

QIAGEN Revolutionizes Diagnostic Testing with HSA Approval of QIAstat-Dx Meningitis/Encephalitis Panel

QIAGEN, a global leader in molecular diagnostics, proudly announces the approval of its QIAstat-Dx Meningitis/Encephalitis Panel by the Health Sciences Aut...

February 06, 2024 | News

QIAGEN Launches New Syndromic Tests in India for Rapid Disease Diagnosis

QIAGEN launches QIAstat-Dx Gastrointestinal Panel 2 and Meningitis/Encephalitis Panel, joining the Respiratory SARS-CoV-2 Panel QIAstat-Dx s...

February 06, 2024 | News

DELFi Diagnostics Launches Fragmentome-Based Cancer Treatment Monitoring Assay

DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer detection, announced availability of the comp...

February 04, 2024 | News

ASPIRE Consortium Tackles Rising Lung Cancer in Asia-Pacific

Lung cancer has a significant health and economic impact in the region. It is the most prevalent cancer, accounting for about 1 million deaths per year, an...

February 04, 2024 | News

Genmab and Pfizer Announce European Medicines Agency Validation for Tisotumab Vedotin in Cervical Cancer

Genmab A/S (Nasdaq: GMAB) and Pfizer, Inc. (NYSE: PFE) have reported that the European Medicines Agency (EMA) has validated the marketing authorization app...

February 02, 2024 | News

Biosyngen's BST02 Granted FDA Fast Track for Liver Cancer Treatment

Fast track is a process designed to facilitate development, and accelerate the review of drugs to treat serious or life-threatening conditions and fill an ...

February 02, 2024 | News

Agilent and Incyte Team Up for Advanced Diagnostics in Hematology & Oncology

The value of the companion diagnostics market is predicted to expand to nearly US $14B by 2030, driven in part by the power of these tests to inform t...

February 01, 2024 | News

Vertex's Breakthrough VX-548: Transforming Pain Management with Rapid Relief and Safety, A New Era in Acute Pain Solutions

Treatment with VX-548 led to statistically significant improvement in pain compared to placebo as well as a clinically meaningful reduction in pain from ...

January 31, 2024 | News

Stay Connected